CMT-and-Genetic-Testing-Why-Is-It-Important

…process, so if a test is available, it can lead to earlier diagnosis. Finally, genetic diagnosis may help direct treatments and similarly can discontinue ineffective treatments and focus on ones…

TMJulia_23

…Accelerate Research (CMTA-STAR), our initiative which is striving to find effective treatments for CMT, we are also doing everything we can at the CMTA to ensure a brighter future for…

Taysha Letter to the GAN Community – 9.19.2023

treatment of giant axonal neuropathy (GAN). This decision follows the receipt of feedback from the United States (U.S.) Food and Drug Administration (FDA) regarding a registrational path for TSHA-120. FDA…

Type1_Research_Developments_6-2020

As part of this multi-pronged approach to identifying novel treatments for demyelinating CMT, the CMTA is supporting several promising therapeutic opportunities in collaboration with more than a dozen key partners:…

Type2_Research_Developments_6-2020

…stem cells to develop assays and test additional libraries of drugs for treatment in CMT2E. ● We are supporting work in Dr. Ron Liem’s lab at Columbia University to screen…

2020_STAR_Agenda_Axonal_CMT

…CMTA’s funding and operations focus is on translational research that will lead as directly as possible to therapeutic treatments for CMT. Axonal forms of CMT affect the “electrical wire” that…

CMTA_2019-2020_Audited_Financial_Statements

…and supports research into the cause, treatment and cure of CMT disorders. The Association also facilitates education and support for persons affected by CMT disorders. (2) SUMMARY OF SIGNIFICANT ACCOUNTING…

NeuropathicPainCMT_GCarter_etal

…BS. Neuropathic pain of peripheral origin: advances in pharmacologic treatment. Neurology 1995;45(Suppl9):17-25. 21. Victor M, Adams R. Diseases of peripheral nerve. In: Victor M, Adams R, editors. Principles of neurology….
…employees, directors, officers, and other stakeholders of the organization, on a confidential and anonymous basis.  The receipt, retention, and treatment of complaints received by the organization regarding accounting, internal…

CMTA Whistleblower Policy

…employees, directors, officers, and other stakeholders of the organization, on a confidential and anonymous basis.  The receipt, retention, and treatment of complaints received by the organization regarding accounting, internal…